-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$17.50195.11% Upside
Solid Biosciences Inc. Frequently Asked Questions
-
What analysts cover Solid Biosciences Inc.?
Solid Biosciences Inc. has been rated by research analysts at Leerink Partners, Piper Sandler, Barclays, Raymond James in the past 90 days.